There is reason for genuine American optimism this week as researchers at Tel Aviv University published what looks like a major advance in the fight against ALS, the merciless disease that robs families of their loved ones. The team identified a muscle-derived microRNA, miR-126, whose loss allows toxic TDP-43 protein to accumulate at neuromuscular junctions, and restoring it reversed nerve damage in lab-grown human tissues and in ALS-model mice, according to the published study in Nature Neuroscience on October 3, 2025.
The science is technical but the bottom line is unmistakable: a naturally occurring RNA signal from muscle to nerve appears to act as a brake on the very protein that drives degeneration in many ALS cases, and replenishing that signal halted degeneration and even promoted regeneration in preclinical models. These findings, replicated across cell cultures and animal models, give biomedical researchers a plausible gene-therapy target rather than another speculative theory, and the data were summarized in international reports as a tangible step toward an eventual treatment.
Conservatives should be the first to celebrate this kind of breakthrough because it is the product of curiosity, hard work, and a research culture unafraid to pursue bold solutions — exactly the kind of scientific entrepreneurship America and Israel have always championed. When governments stop politicizing science and let talented teams compete and collaborate, real cures follow; this discovery is the sort of proof that free minds and free markets deliver results that bureaucratic, one-size-fits-all approaches almost never do.
The researchers themselves were careful to note this is an early but promising avenue: the work so far is preclinical and will require further testing, safety work, and clinical trials before a gene therapy could be offered to patients. Responsible conservatives applaud the cautious optimism while insisting on a fast, efficient regulatory pathway so American and Israeli patients can benefit without needless delay.
On a different but uplifting note, Newsmax’s Israel correspondent Jodie Cohen sat down with Walter Bingham, whom Guinness recognizes as the world’s oldest working journalist, a Holocaust survivor who still reports with raw conviction and clarity. Bingham’s life — from Kindertransport refugee to a centenarian voice for truth in Jerusalem — is a living rebuke to the fashionable elites who embrace victimhood and moral relativism; his tenacity embodies the values conservatives hold dear.
Bingham’s perspective matters now more than ever because he has watched history repeat itself and refuses to be silent about growing antisemitism and threats to Western civilization. Hearing his reflections through a Newsmax report reminds patriotic Americans that journalism’s purpose is to bear witness and to fight for facts and freedom, not to conspire with fashionable narratives that weaken our societies.
So what should hardworking Americans take from these stories? Back scientific innovation, defend our allies who are producing life-saving advances, and honor voices like Walter Bingham who remind us of the cost of liberty and the duty to resist hatred. If we support policies that keep research strong, streamline approvals, and stand shoulder-to-shoulder with Israel against the forces that threaten Western values, we will be doing right by the patients waiting for cures and the generations that fought to preserve our freedoms.

